Methotrexate Decreases the Level of PCSK9—A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data - Publication - Bridge of Knowledge

Methotrexate Decreases the Level of PCSK9—A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data

Abstract

Citations

2 4

CrossRef
0

Web of Science
2 4

Scopus

Authors (5)

Julita Krahel
Anna Baran dr hab. n. med.
Tomasz Kamiński
Magdalena Maciaszek
Iwona Flisiak

Cite as

Full text

full text is not available in portal

full content of the article see on external site open in new tab

Details

Category:: Magazine publication
Type:: Magazine publication
Published in:: Journal of Clinical Medicine no. 9, edition 4,
ISSN: 2077-0383
ISSN:: 2077-0383
Publication year:: 2020
DOI:: Digital Object Identifier (open in new tab) 10.3390/jcm9040910
Verified by:: No verification

seen 57 times